Diagnostics (Mar 2024)

Congenital Heart Defects in Patients with Molecularly Confirmed Sotos Syndrome

  • Giulio Calcagni,
  • Federica Ferrigno,
  • Alessio Franceschini,
  • Maria Lisa Dentici,
  • Rossella Capolino,
  • Lorenzo Sinibaldi,
  • Chiara Minotti,
  • Alessia Micalizzi,
  • Viola Alesi,
  • Antonio Novelli,
  • Anwar Baban,
  • Giovanni Parlapiano,
  • Domenico Coviello,
  • Paolo Versacci,
  • Carolina Putotto,
  • Marcello Chinali,
  • Fabrizio Drago,
  • Andrea Bartuli,
  • Bruno Marino,
  • Maria Cristina Digilio

DOI
https://doi.org/10.3390/diagnostics14060594
Journal volume & issue
Vol. 14, no. 6
p. 594

Abstract

Read online

Sotos syndrome is an autosomal dominant condition characterized by overgrowth with advanced bone age, macrodolicocephaly, motor developmental delays and learning difficulties, and characteristic facial features caused by heterozygous pathogenetic variants in the NSD1 gene located on chromosome 5q35. The prevalence of heart defects (HDs) in individuals with Sotos syndrome is estimated to be around 15–40%. Septal defects and patent ductus arteriosus are the most commonly diagnosed malformations, but complex defects have also been reported. The aim of our study was to analyze the prevalence of HD, the anatomic types, and the genetic characteristics of 45 patients with Sotos syndrome carrying pathogenetic variants of NSD1 or a 5q35 deletion encompassing NSD1, who were followed at Bambino Gesù Children’s Hospital in Rome. Thirty-nine of the forty-five patients (86.7%) had a mutation in NSD1, while six of the forty-five (13.3%) had a deletion. Most of the patients (62.2%, 28/45) were male, with a mean age of 14 ± 7 years (range 0.2–37 years). A total of 27/45 (60.0%) of the patients had heart defects, isolated or combined with other defects, including septal defects (12 patients), aortic anomalies (9 patients), mitral valve and/or tricuspid valve dysplasia/insufficiency (1 patient), patent ductus arteriosus (3 patients), left ventricular non-compaction/hypertrabeculated left ventricle (LV) (4 patients), aortic coarctation (1 patient), aortopulmonary window (1 patient), and pulmonary valve anomalies (3 patients). The prevalences of HD in the two subgroups (deletion versus intragenic mutation) were similar (66.7% (4/6) in the deletion group versus 58.91% (23/39) in the intragenic variant group). Our results showed a higher prevalence of HD in patients with Sotos syndrome in comparison to that described in the literature, with similar distributions of patients with mutated and deleted genes. An accurate and detailed echocardiogram should be performed in patients with Sotos syndrome at diagnosis, and a specific cardiological follow-up program is needed.

Keywords